Page 6 - Flipbook
P. 6
Learning Objectives
By the end of this program, participants will be able to:
• review recent data on first line strategies for advanced
urothelial carcinoma
• discuss novel and emerging targets for patients with pre-
treated disease
• highlight emerging and future clinical trials to answer unmet
needs